J Korean Radiol Soc.  1996 Jul;35(1):1-11.

Thrombolytic Treatment for Acute Ischemic Cerebral Stroke: Intraarterial Urokinase Infusion vs. Intravenous Heparin and Urokinase Infusion

Affiliations
  • 1Department of Diagnostic Radiology, Asan Medical Center, University of Ulsan College of Medicine, Korea.

Abstract

PURPOSE
To evaluate the efficacy and limitation of intra-arterial urokinase (IAUK) infusion for treatment of acute cerebral stroke.
MATERIALS AND METHODS
Twenty-seven acute cerebral stroke patients treated with IAUK infusion within six hours of stroke onset were reviewed. All patients showed normal initial brain findings on CT.In 21 patients, urokinase(5-15 X 105IU) was administered through a microcatheter placed into or proximal to occluded segment. Mechanical disruption of thrombus by guidewire was performed in 17 patients. Angiographic and clinical responses and complications after IAUK infusion, were evaluated and the results were compared with thoseof intravenous heparin(N=19) and urokinase infusion(n=19).
RESULTS
Complete or partial angiographic recanalization of occluded segment was found in 18 patients(67%), and neurologic improvement was followed in 14patients(52%). The degree of improvement on the stroke scale score after IAUK infusion was statistically more significant(p<0.05) than that shown after intravenous heparin and urokinase infusion. Complications after IAUK infusion were large(15%) and small amount intracerebral hemorrhage(15%), contrast leakage into brain parenchyma(11%), and gastrointestinal bleeding(4%). Between the IAVK and the intravenous urokinase infusion group, differences in extent and types of complications were statistically insignificant, but were significantly higherin those two groups than in the intravenous heparin infusion group.
CONCLUSION
IAUK infusion may be effectivefor the treatment of acute cerebral stroke.

Keyword

Thrombolysis; Thrombosis, arterial; Cerebral blood vessels, thrombosis

MeSH Terms

Brain
Heparin*
Humans
Stroke*
Thrombosis
Urokinase-Type Plasminogen Activator*
Heparin
Urokinase-Type Plasminogen Activator
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr